On 1 August 2018, the Commission requested the Authority to carry out an evaluation on the new genotoxicity data for Annatto E generated by the applicant and to indicate whether it is possible to conclude on the safety of this annatto extract. The Authority was also requested to carry out a new exposure assessment for bixin and norbixin, on the basis of the revised uses and use levels of bixin and norbixin submitted by the applicant in the form of three alternative scenarios.
Recital 16, Regulation (EU) 2020/771
In forcesince 11 Jun 2020